Role Definition
| Field | Value |
|---|---|
| Job Title | Clinical Research Coordinator |
| Seniority Level | Mid-Level |
| Primary Function | Manages day-to-day operations of clinical trials at the site level — recruits and screens participants, obtains informed consent, conducts study visits, collects data in electronic case report forms (eCRFs), ensures protocol compliance, reports adverse events, and coordinates with sponsors, CROs, and IRBs. |
| What This Role Is NOT | Not a Clinical Research Associate/Monitor (CRA) who visits sites on behalf of the sponsor. Not a Principal Investigator (physician who bears ultimate medical responsibility). Not a data manager or biostatistician. Not a regulatory affairs specialist at the sponsor level. |
| Typical Experience | 3-7 years. CCRC (Certified Clinical Research Coordinator) or CCRP common but not legally required. Bachelor's in life sciences or nursing typical. |
Seniority note: Entry-level CRCs (0-2 years) doing primarily data entry and scheduling would score deeper Yellow or borderline Red. Senior CRCs or clinical research managers who oversee multiple studies, mentor staff, and handle complex protocol deviations would score higher Yellow or borderline Green.
Protective Principles + AI Growth Correlation
| Principle | Score (0-3) | Rationale |
|---|---|---|
| Embodied Physicality | 0 | Office and clinic-based. No unstructured physical environments. Site visits and participant assessments happen in controlled clinical settings. |
| Deep Interpersonal Connection | 2 | Informed consent is a relationship-driven process — participants must trust the CRC with their health decisions, adverse event disclosure, and trial continuation. CRCs are often the primary human touchpoint for trial participants over months or years. |
| Goal-Setting & Moral Judgment | 1 | Some judgment in protocol deviation decisions and participant safety escalations, but operates within well-defined protocols set by investigators and sponsors. Escalates rather than decides on medical questions. |
| Protective Total | 3/9 | |
| AI Growth Correlation | 0 | AI adoption in clinical trials is neutral to this role — it automates CRC tasks (data entry, query resolution) but also enables more trials (DCTs expand volume). Net effect uncertain. |
Quick screen result: Protective 3 + Correlation 0 = Likely Yellow Zone (proceed to quantify).
Task Decomposition (Agentic AI Scoring)
| Task | Time % | Score (1-5) | Weighted | Aug/Disp | Rationale |
|---|---|---|---|---|---|
| Protocol compliance & study conduct oversight | 25% | 2 | 0.50 | AUGMENTATION | AI flags protocol deviations and scheduling conflicts, but the CRC must interpret ambiguous situations — when a participant's condition changes mid-visit, whether a deviation is reportable, how to adapt procedures. Human judgment leads; AI assists. |
| Participant recruitment, screening & informed consent | 20% | 2 | 0.40 | AUGMENTATION | AI tools (Medidata AI, TrialX) improve patient matching and pre-screening. But informed consent requires face-to-face trust-building, answering participant questions, and assessing comprehension — the human IS the value. |
| Participant visits & clinical assessments | 15% | 1 | 0.15 | NOT INVOLVED | Conducting scheduled visits, collecting vitals, performing study-specific assessments, and managing participant distress or confusion. Physical presence with a real patient in a real clinic. AI not involved in this interaction. |
| Data collection, CRF completion & query resolution | 20% | 4 | 0.80 | DISPLACEMENT | Medidata Rave AI, Veeva Vault CDMS, Oracle ClearTrial auto-populate fields, flag discrepancies, and resolve routine queries. AI agents increasingly handle end-to-end data cleaning workflows. CRC reviews and approves but does not manually enter most data. |
| Regulatory documentation & IRB submissions | 10% | 4 | 0.40 | DISPLACEMENT | AI drafts IRB amendments, generates regulatory binders, tracks document expiry, and pre-fills submission forms. Veeva Vault eTMF automates trial master file management. Human reviews and submits but AI produces the documents. |
| Adverse event reporting & safety monitoring | 5% | 3 | 0.15 | AUGMENTATION | AI detects potential adverse events in patient data and pre-populates safety reports. But the CRC must validate clinical context, interview the participant, assess causality with the investigator, and make the judgment call on severity. Human-led, AI-accelerated. |
| Site coordination & sponsor/CRO communication | 5% | 2 | 0.10 | AUGMENTATION | Managing relationships with monitors, investigators, pharmacy, and labs. AI schedules and tracks action items, but navigating site politics, resolving conflicts, and building trust with sponsors requires human skill. |
| Total | 100% | 2.50 |
Task Resistance Score: 6.00 - 2.50 = 3.50/5.0
Displacement/Augmentation split: 30% displacement, 55% augmentation, 15% not involved.
Reinstatement check (Acemoglu): Yes. AI creates new CRC tasks — validating AI-generated data queries, overseeing decentralised trial technology (wearables, ePRO platforms), auditing AI site-selection recommendations, and managing hybrid virtual/in-person visit workflows. The role is shifting from data handler to data overseer and participant advocate.
Evidence Score
| Dimension | Score (-2 to 2) | Evidence |
|---|---|---|
| Job Posting Trends | 0 | CRC postings remain stable. Clinical trials growing 6-8% annually, but decentralised trials and AI efficiencies mean fewer CRCs needed per trial. BLS projects 4% growth for 29-9099 (Healthcare Practitioners, All Other) — as fast as average but unremarkable. |
| Company Actions | 0 | No major companies have cut CRC roles citing AI. IQVIA, PPD, and Covance continue hiring. However, sponsors are investing heavily in AI platforms (Medidata, Veeva, Medable) that reduce per-site CRC workload. CCRPS (2025) projects AI will "compress teams" by 2028 but not eliminate the coordinator role. |
| Wage Trends | 0 | Average CRC salary $60K-$72K (ZipRecruiter, Glassdoor, Comparably 2025-2026). Wages stable, tracking inflation. No premium signals, no decline. CCRC certification adds modest premium but no surge. |
| AI Tool Maturity | -1 | Production tools deployed: Medidata Rave AI (auto-population, query management), Veeva Vault CDMS/eTMF (document automation), Medable CRA Agent (site monitoring), Oracle Health Sciences (data cleaning). These tools perform 50-80% of data management tasks with human oversight. Not yet replacing CRCs outright but clearly compressing the administrative workload. |
| Expert Consensus | 0 | Mixed. ACRP (Dec 2025): "AI is reaching into every corner of the clinical trial lifecycle" but positions CRCs as "driving site-level innovation." BekHealth: "AI isn't replacing CRCs — it's redefining their role." CCRPS: "AI will compress teams by 2028." Consensus is transformation, not elimination — but timeline debate is real. |
| Total | -1 |
Barrier Assessment
Reframed question: What prevents AI execution even when programmatically possible?
| Barrier | Score (0-2) | Rationale |
|---|---|---|
| Regulatory/Licensing | 1 | No formal licence required for CRCs (CCRC/CCRP are voluntary certifications). However, FDA 21 CFR Part 11 requires human accountability for clinical data integrity, ICH-GCP (E6 R2/R3) mandates trained personnel at sites, and IRBs require named study staff on delegation logs. These regulatory frameworks assume human coordinators. |
| Physical Presence | 1 | Participant visits, vitals collection, specimen handling, and informed consent traditionally require in-person presence. Decentralised trials are eroding this — eConsent, remote monitoring, and wearables reduce but do not eliminate the need for a human at the site. |
| Union/Collective Bargaining | 0 | No union representation for CRCs. At-will employment in most settings. Academic medical centre CRCs may have some institutional protections but no formal collective bargaining. |
| Liability/Accountability | 1 | When a protocol deviation harms a participant, accountability flows through the site — PI, then CRC. The CRC signs off on data accuracy, consent documentation, and adverse event timelines. AI cannot bear this responsibility. Moderate liability, not criminal-level. |
| Cultural/Ethical | 1 | Participants in clinical trials — often seriously ill — place significant trust in the CRC as their primary point of contact. IRBs and ethics committees expect human oversight of the consent process. The idea of an AI managing a cancer patient's trial participation faces cultural resistance, though less intense than therapy or end-of-life care. |
| Total | 4/10 |
AI Growth Correlation Check
Confirmed at 0 (Neutral). More AI in clinical trials creates efficiency that could reduce CRC headcount per study, but the global clinical trial market is expanding (6-8% CAGR), decentralised trials create new coordination demands, and the pipeline of trials keeps growing. These forces roughly cancel out. The CRC role does not exist because of AI growth (not Accelerated) nor does AI adoption directly shrink demand (not Negative). It is a bystander — transformed by AI but neither created nor destroyed by it.
JobZone Composite Score (AIJRI)
| Input | Value |
|---|---|
| Task Resistance Score | 3.50/5.0 |
| Evidence Modifier | 1.0 + (-1 x 0.04) = 0.96 |
| Barrier Modifier | 1.0 + (4 x 0.02) = 1.08 |
| Growth Modifier | 1.0 + (0 x 0.05) = 1.00 |
Raw: 3.50 x 0.96 x 1.08 x 1.00 = 3.6288
JobZone Score: (3.6288 - 0.54) / 7.93 x 100 = 39.0/100
Zone: YELLOW (Green >=48, Yellow 25-47, Red <25)
Sub-Label Determination
| Metric | Value |
|---|---|
| % of task time scoring 3+ | 35% |
| AI Growth Correlation | 0 |
| Sub-label | Yellow (Moderate) — <40% task time scores 3+ |
Assessor override: None — formula score accepted.
Assessor Commentary
Score vs Reality Check
The 39.0 score places this role firmly mid-Yellow, and the label is honest. The 3.50 Task Resistance is relatively strong for Yellow — driven by the participant-facing core (35% at score 1-2) that AI genuinely cannot touch. But the 30% displacement in data management and regulatory documentation is real and accelerating. Barriers at 4/10 provide modest friction, not structural protection — no formal licence, no union, moderate liability. If barriers eroded (e.g., FDA accepted AI-validated data without CRC sign-off), this role would drop to low Yellow (~30-32). It is not barrier-dependent in the way that, say, a pharmacist is, but barriers are doing more work than the score alone suggests.
What the Numbers Don't Capture
- Market growth vs headcount growth. The clinical trial market is expanding 6-8% annually, and decentralised trials are creating new site-level coordination demands. But AI efficiency gains mean each CRC handles more trials. Revenue growth in clinical research does not equal proportional hiring growth in CRCs — sponsors are investing in platforms, not people.
- Bimodal distribution. The CRC role is split between deeply human work (consent, participant visits, safety judgment) and deeply automatable work (data entry, query resolution, regulatory filing). The 3.50 average masks a role where half the day looks Green and half looks Red. Individual CRCs who spend most of their time on data entry are far more exposed than those who spend most of their time with participants.
- Decentralised trial wildcard. DCTs could go either way — they may reduce the need for site-based CRCs (remote monitoring, eConsent) or create new hybrid coordinator roles that blend in-person and virtual care. The trajectory is unclear and could meaningfully shift the score in either direction within 2-3 years.
Who Should Worry (and Who Shouldn't)
If your daily work is primarily entering data into Medidata Rave, resolving queries, and filing regulatory documents — you are functionally closer to Red than this Yellow label suggests. These are the exact tasks that Veeva AI Agents and Medidata AI are automating at production scale. The CRC who spends 80% of their time on eCRFs is the most exposed.
If you are the participant's primary point of contact — running consent visits, managing complex multi-visit protocols, handling adverse events with clinical judgment, and coordinating between investigators and sponsors — you are safer than Yellow suggests. This is the human core that AI cannot replicate.
The single biggest separator: whether you are a data handler or a participant advocate. The data handlers are being absorbed by platforms. The participant advocates are being freed by those same platforms to do more of what they do best.
What This Means
The role in 2028: The surviving CRC is a participant-experience specialist and protocol-judgment expert, not a data clerk. AI handles data entry, query resolution, and routine regulatory filings. The CRC spends their time on informed consent, participant relationships, adverse event management, and coordinating increasingly complex hybrid (in-person + decentralised) trial designs. A CRC managing 3-4 studies in 2024 manages 5-7 in 2028 with AI tooling.
Survival strategy:
- Master the AI platforms. Medidata Rave AI, Veeva Vault, and Medable are not optional — they are the operating system of modern trials. The CRC who can configure, troubleshoot, and optimise these tools is the one who stays.
- Lean into participant-facing work. Informed consent, patient retention, and adverse event management are the irreducible human core. Build expertise in complex consent (paediatric, cognitive impairment, rare disease) and patient engagement strategies.
- Specialise in decentralised trials or complex therapeutic areas. DCT coordination (wearables, ePRO, remote visits) and oncology/gene therapy trials create demand for CRCs with niche expertise that AI cannot easily replicate.
Where to look next. If you are considering a career shift, these Green Zone roles share transferable skills with this role:
- Registered Nurse (Clinical) (AIJRI 82.2) — clinical assessment skills, patient interaction, and regulatory knowledge transfer directly to bedside nursing
- Nurse Practitioner (Mid-to-Senior) (AIJRI 67.5) — with additional education, CRC clinical trial experience provides strong foundation for advanced practice roles
- Medical and Health Services Manager (Senior) (AIJRI 53.1) — study management, regulatory compliance, and site coordination skills map to healthcare administration
Browse all scored roles at jobzonerisk.com to find the right fit for your skills and interests.
Timeline: 3-7 years for significant role transformation. The administrative compression is happening now (Medidata AI, Veeva AI Agents rolling out through 2026), but the participant-facing core and regulatory inertia extend the full transformation timeline.
